India’s biotech sector continues its strong growth trajectory, with the national bioeconomy crossing the USD 165 billion mark in 2024. As India evolves from being the “pharmacy of the world” to a global biomanufacturing and innovation hub, the next phase of growth will be defined by how effectively we synthesize biology with digital technologies. Achieving the ambitious USD 300 billion bioeconomy target by 2030 will depend on this seamless integration of biological sciences with data computation and intelligent systems.
With this background, the theme for the BioEconomy Conclave 2026 will be “Synthesizing Biology and Bits – The Dawn of the Biodigital BioEconomy”. The theme captures India’s transition into a Biodigital BioEconomy, where biology converges with artificial intelligence, cloud computing, IoT, robotics and big data to redefine innovation, manufacturing, healthcare, agriculture and sustainability. The conclave will act as a strategic platform to connect India’s IT leadership with its growing biotech capabilities, catalysing scalable, technology-driven bioeconomic growth.
The one-day conclave will feature high-impact sessions aligned with this bio digital vision, including:
The conclave will bring together industry leaders, policymakers, investors, startups, researchers, and global experts to define the “India Model for the bio digital bioeconomy”, one that is low-cost, high-tech, inclusive and globally scalable.
